Inactive Instrument
Kadimastem Stock OTC Markets
Stocks
KMSTF
IL0011284614
Biotechnology & Medical Research
OTC Markets Traded
| Market Cap | 52.09M 45.21M 41.67M 39.04M 72.95M 4.99B 74.47M 497M 192M 2.4B 196M 191M 8.36B | P/E Ratio 2024 * |
-
| P/E Ratio 2025 | -2.81x |
|---|---|---|---|---|---|
| Enterprise Value | 50.25M 43.6M 40.19M 37.66M 70.37M 4.81B 71.83M 479M 186M 2.32B 189M 185M 8.06B | EV / Sales 2024 * |
-
| EV / Sales 2025 | - |
| Free-Float |
35.62% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -0.78% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.78% | +153.00% | - | - | 17.58M | |
| -0.55% | +0.82% | -16.08% | -12.85% | 42.96B | |
| +3.27% | +3.41% | +275.37% | +509.70% | 31.73B | |
| -0.60% | -1.63% | +13.40% | -14.84% | 30.22B | |
| +1.97% | -1.52% | -3.81% | +24.76% | 28.94B | |
| +4.09% | -1.98% | +11.99% | +17.37% | 23.87B | |
| -1.05% | +3.89% | +55.23% | +116.45% | 13.57B | |
| -0.40% | -1.29% | +6.06% | +7.59% | 12.96B | |
| +3.02% | +6.34% | - | - | 13.39B | |
| -1.43% | -1.54% | +105.88% | +76.16% | 12.2B | |
| Average | +0.74% | -0.71% | +56.01% | +90.54% | 23.31B | |
| Weighted average by Cap. | +1.04% | -1.08% | +54.71% | +96.26% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -26.55M -23.04M -21.24M -19.9M -37.18M -2.54B -37.96M -253M -98.09M -1.23B -99.68M -97.53M -4.26B | -8.3M -7.2M -6.64M -6.22M -11.62M -795M -11.87M -79.2M -30.66M -383M -31.16M -30.49M -1.33B |
| Net Debt | 7.35M 6.38M 5.88M 5.51M 10.29M 703M 10.5M 70.11M 27.14M 339M 27.58M 26.99M 1.18B | -1.85M -1.6M -1.48M -1.38M -2.59M -177M -2.64M -17.61M -6.82M -85.2M -6.93M -6.78M -296M |
Employees
11
